ABSTRACT
Objective: Studies from large administrative databases have demonstrated associations between institutional case volume and outcomes after lower extremity bypass (LEB). We hypothesized that increased institutional and surgeon volume would be associated with improved outcomes after LEB. Using a national, prospectively collected clinical database, the objective of this study was to determine the effects of both surgeon and institutional volume on outcomes after LEB.
Methods:
The Vascular Quality Initiative (VQI) was queried to identify all LEBs for critical limb ischemia or claudication between 2004 and 2014. Average annual case volume was calculated by dividing an institution's or surgeon's total LEB volume by the number of years they reported to the VQI. Institutional and surgeon volumes were analyzed as continuous variables to determine the impact of volume on major adverse cardiac events (MACEs), major adverse limb events (MALEs), graft patency, and amputation-free survival. Hierarchical regression models were used with cases clustered by surgeon and center. Time-dependent outcomes were evaluated with multivariable shared frailty Cox proportional hazards models. 
Conclusions:
In contradistinction to previous studies, there was no relationship in this study between institutional LEB volume and outcomes after LEB. However, greater average annual surgeon volume was associated with improved primary patency and decreased risk of MALEs. Open LEB remains a safe and effective procedure for limb salvage. Limb-related outcomes in critical limb ischemia and claudication will be optimized if surgeons maintain adequate volume of LEB. (J Vasc Surg 2017;66:1457-63.)
Procedural volume has been positively associated with patient outcomes across a wide variety of procedures and institutional settings, including vascular surgery. [1] [2] [3] [4] [5] [6] [7] [8] This association is studied most often in relation to postoperative mortality, but it has been described for more disease-specific outcomes as well, including stroke after carotid endarterectomy 9 and amputation after lower extremity arterial bypass. 10, 11 Traditionally, institutional volume has been the primary independent variable, but several studies examining the role of surgeon volume have been conducted as well.
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The reasons for the volume-outcome association are thought to be several and include both institutional and provider factors. It has been shown that much of the difference at the institutional level is in the capacity to rescue patients after a complication rather than in lower overall complication rates. 16, 17 More technically demanding operations seem to show a stronger volume-outcome relationship than those less technically challenging. 1, 17 Lower extremity bypass (LEB) actually describes a collection of several different procedures of varying complexity and technical difficulty, and this heterogeneity has been a problem for studies examining the volume-outcome relationship in LEB.
Notably, the majority of studies demonstrating these relationships have largely been conducted using administrative or billing databases. This was necessary, given the need to measure a large number of patients across multiple institutions and the lack of adequate breadth in most clinical databases. However, the national Vascular Quality Initiative (VQI) is especially well suited to address these questions as it captures deidentified clinical data, including short-and long-term follow-up, at hundreds of centers across the country, and both centers and surgeons are tracked using anonymized identifiers. 19 The aim of this study was to investigate the impact of institutional and surgeon volume on outcomes after LEB for critical limb ischemia (CLI) and claudication using a prospective multi-institutional clinical database with long-term follow-up of a large sample of patients.
METHODS
Sample. The Society for Vascular Surgery's VQI is a collection of >10 individual procedural registries that prospectively collect patient and clinical data and capture both short-and long-term outcomes from >220 institutions across the country. Deidentified data from the national VQI open LEB registry were provided by the VQI and included operations performed between 2004 and 2014. Exclusion criteria included patients younger than 18 years and those undergoing LEB for acute limb ischemia. Institutional Review Board approval and informed consent were waived, given the deidentified nature of the data.
Definitions. Low, medium, and high surgeon volume was based on the lowest 25th percentile, 25th to 75th percentile, and highest 75th percentile, rounded to the nearest round number of cases. Low, medium, and high center volume was similarly determined. Complex operations were defined as those that included any tibial or more distal target, those with the inflow vessel below the superficial femoral artery, and a femoral to belowknee popliteal bypass with anything other than prosthetic or single-segment saphenous vein. Major adverse cardiac events (MACEs) included death, myocardial infarction (MI), and stroke; MI and stroke were captured only out to 30 days. Major adverse limb events (MALEs) included major amputation and graft revision, either open or endovascular, of the bypass. Primary patency is patency of the original bypass without any intervention required to maintain patency. Primary assisted patency includes primary patency as well as a bypass that was revised because of stenosis but was not completely occluded. Secondary patency includes bypasses in the aforementioned categories as well as those bypasses that are recanalized and patent after occlusion.
Study design. This study design accounts for the clustered, nonindependent nature of outcomes by using hierarchical multilevel mixed-effects regression models.
In the case of time-to-event analyses, the standard errors are adjusted using a shared frailty methodology that also accounts for clustering.
Statistical analysis. Preoperative demographic variables and comorbidities as well as outcomes including mortality, amputation, patency, MACE, and MALE were analyzed. Limb outcomes (MALE and amputation-free survival) were evaluated separately in patients with CLI and those with claudication. Differences in categorical variables were tested using Pearson c 2 test, and differences in continuous variables were tested using the Wilcoxon rank sum test. Measures of central tendency are presented as medians with interquartile range (IQR). Statistical significance for all tests was two tailed and set at a ¼ .05. For the purposes of modeling, volume was treated as a continuous function and tested using both restricted cubic spline and linear functions and then compared. These functions were not significantly different, so volume was modeled as a linear function. Multivariable models included all patient and operative characteristics that were significant at the P # .2 level on univariate analysis for the outcome of interest. Analysis was performed using Stata version 14.0 software (Stata Corp, College Station, Tex).
RESULTS
Sample. From 2004 to 2014, the VQI contained 20,672 LEB operations. After exclusion of operations for acute limb ischemia and asymptomatic patients as well as exclusion of centers with <50% long-term follow-up as defined by the VQI, the sample for this study was 14,678 bypasses performed at 114 institutions by 587 surgeons. Overall, 67% of the patients were male, with a median age of 67 years (IQR, 59-75 years; Table I ). Hypertension and smoking were the most common comorbidities at 88% and 84% of the study population, respectively. Almost 70% of bypass patients had CLI, defined as either rest pain or tissue loss (Rutherford 4-6), with the remainder being claudicants (30% Recommendation: The authors suggest that maintaining adequate surgeon volume is essential to achieve good outcomes after lower extremity bypass procedures.
preoperative ankle-brachial index was 0.48 (IQR, 0.33-0.64). Approximately 69% of patients had at least 9 months of follow-up recorded in the VQI, with an overall median follow-up time of 314 days (IQR, 28-393 days).
Volumes. Average annual institutional volume ranged from 1.0 to 137.5 LEBs per year, with a median of 26.9 (IQR, 14-45.3). Average annual surgeon volume ranged from 1 to 52 LEBs per year, with a median of 5.7 (IQR, 2.5-9.3). Center volume cutoffs for the low-, medium-, and high-volume groups were approximately <14, 14 to 45, and >450 cases per year. For surgeons, the volume cutoffs were <2, 2 to 10, and >10 bypass operations per year. Overall, 695 operations were performed at lowvolume centers, 5298 at moderate-volume centers, and 8149 at centers in the highest volume quartile. By surgeon volume, 355 operations were performed by surgeons in the lowest volume quartile, 5167 in the moderate-volume group, and 8620 in the high-volume group. All strata of surgeon volume were represented in each category of institutional volume. Overall, 6339 operations (43%) were classified as complex (Table II) .
Outcomes. The 30-day mortality for all patients was 2.2%, with an increase to 19.2% at 1 year of those patients with confirmed 1-year follow-up. Within the first year after bypass, 21.9% of patients underwent any amputation; this increased to 23.2% in patients with CLI. Primary patency at 1 year was 75%, and secondary patency was 84.4% at 1 year. Overall, more than a third of patients experienced a postoperative complication (Table III) . In unadjusted analyses, there are no clear trends that apply to all strata of surgeon and center volumes. By strata, MACE appears to vary as a function of surgeon volume in medium-and high-volume centers (Table IV) 
DISCUSSION
This study demonstrates that surgeon but not institutional volume is inversely related to adverse limb events after LEB. Moreover, we find no effect of volume on MACE within 30 days of surgery in adjusted analyses. There is a small but significant reduction in amputation-free survival with increasing surgeon volume in patients with CLI. Compared with the Project of Ex-Vivo vein graft Engineering via Transfection III (PRE-VENT III) trial data, the VQI demonstrates a lower rate of MACE (8.0% vs 4.0%), but this may be for several reasons, including the fact that MI and stroke outcomes are limited to in-hospital events in the VQI and are not captured out to 30 days. 20, 21 In addition, the PREVENT III population was restricted to patients with CLI, who may represent a higher risk cohort than the claudicants. According to a systematic review by Awopetu et al, nine studies have examined the effect of hospital volume on mortality after LEB. They reported that five of those studies demonstrated a positive volume-outcome relationship, whereas the other four did not find any evidence of a volume effect on postoperative mortality, yielding a metaanalysis that supports the effect of increased volume leading to decreased mortality, but this finding is also associated with significant heterogeneity and thus must be interpreted with caution. 22 In the same review, seven studies examined the rates of amputation at low-vs high-volume hospitals, three of which were suitable for inclusion in the meta-analysis. The pooled effect estimate was an OR of 0.88, with low heterogeneity favoring highvolume hospitals. However, of the seven total studies, only three showed a volume-outcome relationship. 22 Our study does not demonstrate any effect of either institutional or surgeon volume on amputation-free survival but does show an effect of surgeon volume on MALEs, which includes major amputation. The median annual surgeon volume for LEB in the VQI is surprisingly low at less than one bypass every 2 months, which could be explained in several ways. First, it is possible that the VQI is capturing a number of general and cardiac surgeons who rarely perform LEB as part of their daily practice. Second, there may be clerical issues with the tracking of individual surgeons in the VQI, resulting in erroneous additional records. Third, the overall rate of open operations has decreased markedly over time as use of endovascular therapies has risen. Finally, the VQI is designed to capture 100% of eligible cases at an institution, and billing records are audited on occasion to ensure compliance; nevertheless, it may be that not all LEBs are being captured, leading to falsely reduced volumes. In a study that examined hospital discharge records in Florida in the early 1990s, the median surgeon volume was considerably higher at 21 LEBs annually, but this is challenging to interpret, given the relative paucity of endovascular intervention in that era. 23 Kantonen et al used a threshold of 10 LEBs per year to distinguish between high-and low-volume surgeons based on a national study conducted in the United Kingdom, also in the early 1990s, that demonstrated higher primary amputation rates for surgeons who performed fewer than 10 LEBs annually, although interestingly, the rates of limb salvage, secondary amputation, length of stay, and mortality were not different between strata of surgical volumes in that study. 24, 25 Benchmarking our surgeon volume data against more current databases is an important next step in terms of validating our findings. It would also potentially highlight an opportunity to improve data fidelity in the VQI if need be, although as a self-selecting sample, it may be difficult to directly compare VQI with Healthcare Cost and Utilization Project/National Inpatient Sample or Centers for Medicare and Medicaid Services data. The decrease in amputation-free survival with increasing surgeon volume is, at face value, counterintuitive. However, based on the MACE data, this finding is driven by amputations rather than by overall survival, and VQI does not distinguish planned vs unplanned amputations. In other words, if revascularization is the precursor operation to permit healing of an amputation, there is no mechanism in the VQI to record this as a planned procedure. This results in a database that may unfairly penalize surgeons for amputations that do not in fact represent a treatment failure. In addition, based on the amputation-free survival data, it becomes clear that the reduction in MALE is driven predominantly by primary patency and the reduced need for interventions to achieve secondary patency. This reduction likely results in cost savings to both patients and the health care system. It also is consistent with the hypothesis that the technical skill of the surgeon, which is associated with operative volume in other studies, may have a significant impact on limb outcomes after bypass. This is likely not reflected in amputation rates because of the equivalency of secondary patency across surgeon and center volumes. The implications of these results, if validated, are broad. Because of the linear nature of the relationship we describe, it is difficult to meet the demand for specific threshold numbers: how many is enough? This applies to training and required case volume, to the ongoing national debate regarding centralization of specialized surgical care, and to individual surgeons who are now being asked about case volumes to determine hospital privileges. Moreover, whereas the rates of secondary patency are equivalent across center and surgeon volumes, the rates of primary patency are not, and this is associated with real costs both to the health care system and to patients in terms of additional procedures required to maintain graft patency over time.
This study is limited in several ways. First, it suffers the same risk of bias as all retrospective nonrandomized observational studies. The risk of bias is compounded by the selection bias inherent in the VQI: centers voluntarily participate in the VQI generally, and in individual surgical modules specifically, and the data are selfreported by surgeons and centers, thus introducing another element of potential bias. It is certainly possible that these decisions may be influenced by the cost of participation as well as by an institution's perception of its performance. This selection bias also makes the VQI unsuitable for following trends in providers or institutions over time, as the early adopters were higher volume tertiary centers but the diversity of participating institutions has broadened considerably during the last decade.
CONCLUSIONS
This study shows that increasing surgeon volume is independently associated in a linear fashion with lower rates of adverse limb events and higher rates of primary patency. Our analysis does not substantiate previous studies that find a relationship between institutional volume and outcomes; center volume is not related to short-term adverse cardiac events, limb outcomes, or overall survival in the VQI. 
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